Skip to main content

Malignancy and CV Risk in Rheumatoid Arthritis

Dr. Jonathan Kay discusses OP0218, OP0219 and OP0211 at EULAR 2023 in Milan, Italy.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.